Boosting immunity after CoronaVac

Adult study participants were recruited to include two equally sized age groups: younger than 60 years and 61 years and older. 1205 individuals, of whom 729 (60·5%) were women and 814 (67·6%) were White, were available for analysis of primary outcomes, which included reactogenicity and immunogenicit...

Ausführliche Beschreibung